The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Relestat, 0.5 mg/ml, eye drops, solution

0.5 milligram(s)/millilitre Eye drops, solution

Allergan Pharmaceuticals IrelandPA0148/062/001

Main Information

Trade NameRelestat, 0.5 mg/ml, eye drops, solution
Active SubstancesEpinastine hydrochloride
Strength0.5 milligram(s)/millilitre
Dosage FormEye drops, solution
Licence HolderAllergan Pharmaceuticals Ireland
Licence NumberPA0148/062/001

Group Information

ATC CodeS01GX Other antiallergics
S01GX10 epinastine


Licence Issued22/08/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back